These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7707689)

  • 1. Prenatal detection of Canavan disease (aspartoacylase deficiency) by DNA analysis.
    Elpeleg ON; Shaag A; Anikster Y; Jakobs C
    J Inherit Metab Dis; 1994; 17(6):664-6. PubMed ID: 7707689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliable prenatal diagnosis of Canavan disease (aspartoacylase deficiency): comparison of enzymatic and metabolite analysis.
    Bennett MJ; Gibson KM; Sherwood WG; Divry P; Rolland MO; Elpeleg ON; Rinaldo P; Jakobs C
    J Inherit Metab Dis; 1993; 16(5):831-6. PubMed ID: 8295397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliable prenatal diagnosis of Canavan disease by measuring N-acetylaspartate in amniotic fluid using liquid chromatography tandem mass spectrometry.
    Al-Dirbashi OY; Kurdi W; Imtiaz F; Ahmad AM; Al-Sayed M; Tulbah M; Al-Nemer M; Rashed MS
    Prenat Diagn; 2009 May; 29(5):477-80. PubMed ID: 19235826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canavan disease: diagnosis and molecular analysis.
    Matalon R
    Genet Test; 1997; 1(1):21-5. PubMed ID: 10464621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease.
    Kaul R; Gao GP; Balamurugan K; Matalon R
    Nat Genet; 1993 Oct; 5(2):118-23. PubMed ID: 8252036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canavan disease: biochemical and molecular studies.
    Matalon R; Kaul R; Michals K
    J Inherit Metab Dis; 1993; 16(4):744-52. PubMed ID: 8412017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal diagnosis of Canavan disease--problems and dilemmas.
    Besley GT; Elpeleg ON; Shaag A; Manning NJ; Jakobs C; Walter JH
    J Inherit Metab Dis; 1999 May; 22(3):263-6. PubMed ID: 10384383
    [No Abstract]   [Full Text] [Related]  

  • 8. The frequency of the C854 mutation in the aspartoacylase gene in Ashkenazi Jews in Israel.
    Elpeleg ON; Anikster Y; Barash V; Branski D; Shaag A
    Am J Hum Genet; 1994 Aug; 55(2):287-8. PubMed ID: 8037206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal detection of Canavan disease by measurement of N-acetyl-L-aspartate in amniotic fluid.
    Kelley RI
    J Inherit Metab Dis; 1993; 16(5):918-9. PubMed ID: 8295422
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel splice site mutation of aspartoacylase gene in a Turkish patient with Canavan disease.
    Rady PL; Penzien JM; Vargas T; Tyring SK; Matalon R
    Eur J Paediatr Neurol; 2000; 4(1):27-30. PubMed ID: 10701101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel aspartoacylase (ASPA) gene mutation in Canavan disease.
    Durmaz AA; Akin H; Onay H; Vahabi A; Ozkinay F
    Fetal Pediatr Pathol; 2012 Aug; 31(4):236-9. PubMed ID: 22468686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The spectrum of mutations of the aspartoacylase gene in Canavan disease in non-Jewish patients.
    Elpeleg ON; Shaag A
    J Inherit Metab Dis; 1999 Jun; 22(4):531-4. PubMed ID: 10407784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canavan disease: from spongy degeneration to molecular analysis.
    Matalon R; Michals K; Kaul R
    J Pediatr; 1995 Oct; 127(4):511-7. PubMed ID: 7562269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterisation and prenatal diagnosis of Asparto-acylase deficiency (Canavan disease)--report of two novel and two known mutations from the Indian subcontinent.
    Bijarnia S; Kohli S; Puri RD; Jacob RJ; Saxena R; Jalan A; Sistermans EA; Mahmood S; Verma IC
    Indian J Pediatr; 2013 Jan; 80(1):26-31. PubMed ID: 22878930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation detection in the aspartoacylase gene in 17 patients with Canavan disease: four new mutations in the non-Jewish population.
    Sistermans EA; de Coo RF; van Beerendonk HM; Poll-The BT; Kleijer WJ; van Oost BA
    Eur J Hum Genet; 2000 Jul; 8(7):557-60. PubMed ID: 10909858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New T530C mutation in the aspartoacylase gene caused Canavan disease with no correlation between severity and N-acetylaspartate excretion.
    Di Pietro V; Cavallari U; Amorini AM; Lazzarino G; Longo S; Poggiani C; Cavalli P; Tavazzi B
    Clin Biochem; 2013 Dec; 46(18):1902-4. PubMed ID: 24036223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable isotope dilution analysis of N-acetylaspartic acid in CSF, blood, urine and amniotic fluid: accurate postnatal diagnosis and the potential for prenatal diagnosis of Canavan disease.
    Jakobs C; ten Brink HJ; Langelaar SA; Zee T; Stellaard F; Macek M; Srsnová K; Srsen S; Kleijer WJ
    J Inherit Metab Dis; 1991; 14(5):653-60. PubMed ID: 1779610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular basis of canavan (aspartoacylase deficiency) disease in European non-Jewish patients.
    Shaag A; Anikster Y; Christensen E; Glustein JZ; Fois A; Michelakakis H; Nigro F; Pronicka E; Ribes A; Zabot MT
    Am J Hum Genet; 1995 Sep; 57(3):572-80. PubMed ID: 7668285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase.
    Francis JS; Wojtas I; Markov V; Gray SJ; McCown TJ; Samulski RJ; Bilaniuk LT; Wang DJ; De Vivo DC; Janson CG; Leone P
    Neurobiol Dis; 2016 Dec; 96():323-334. PubMed ID: 27717881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canavan disease: a review of recent developments.
    Gordon N
    Eur J Paediatr Neurol; 2001; 5(2):65-9. PubMed ID: 11589315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.